Search PubMed⌕ Search

PubMed · 9538288

Posthyperventilation hypoxemia after methacholine inhalation.

Abstract

The hypothesis of this study was that hypoxemia after methacholine (MTH) inhalation is related not only to ventilation/perfusion inhomogeneity, but also to posthyperventilation hypoxemia. To test the hypothesis, we paid special attention to changes in gas exchange and ventilation parameters after MTH inhalation. Six stable asthma patients were investigated, and SaO2, minute ventilation (V.E), oxygen uptake rate in the lung (V.O2), carbon dioxide output rate in the lung (V.CO2), and respiratory exchange ratio (R) were measured. The SaO2 level decreased from a baseline level (before MTH inhalation) of 96.8 +/- 1.0% (mean +/- SD) to the lowest level (the nadir SaO2) of 89.8 +/- 2.1% (p < 0.01) in 200 +/- 50 s after MTH inhalation and gradually increased toward the baseline level. V.CO2 increased just after MTH inhalation (post-MTH) with increased V.E, and decreased at the nadir SaO2 with baseline V.E and PaCO2, indicating a decrease in breath-by-breath V.A and an increase in dead space minute ventilation at the nadir SaO2, but V.O2 remained close to constant. R increased post-MTH, decreased at the nadir SaO2, and thereafter increased gradually toward the baseline level with a time constant of 5.6 min. The addition of CO2 to inspired air partially suppressed hypoxemia. The consensus is that hypoxemia after MTH is solely attributable to the ventilation/perfusion inhomogeneity, but posthyperventilation hypoxemia is another reasonable interpretation of the hypoxemia after MTH with decreased V.A, V.CO2, and R. It is speculated that posthyperventilation normoventilation in respect to V.CO2 with baseline PaCO2 after MTH inhalation resulted in posthyperventilation hypoxemia as a result of relative hypoventilation in respect to V.O2.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T Ogura, H Kobayashi, M Suzuki, T Sato, T Tomita. 1998. Posthyperventilation hypoxemia after methacholine inhalation.. https://doi.org/10.2170/jjphysiol.48.39

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Concurrent carbogen and radiation therapy in children with high-risk brainstem gliomas.

In an attempt to improve local control, we assessed the feasibility of the addition of 4 min of carbogen inhalation (as a radiosensitizer) to daily fractionated radiotherapy in pediatric patients with high grade and/or diffuse brainstem gliomas. Ten patients inhaled carbogen for >90% of the radiation treatments. Median survival time from start of therapy was 0.80 years. Carbogen inhalation did not appear to improve the dismal prognosis.

Administration, Inhalation↗

2. Advances in pharmacotherapy for COPD.

Chronic obstructive pulmonary disease (COPD) is the most common chronic lung disease in the world. In 1999, COPD ranked sixth among the most common causes of death and twelfth as a worldwide burden of disease. It has been estimated that by the year 2020 COPD will be the third leading cause of death and fifth as a worldwide burden of disease. Thus, COPD is a major medical problem and there is evidence that it is increasing throughout the world. Despite recognition of COPD as an important international health problem, COPD has been neglected among common diseases, with little investment in research on its underlying cellular and molecular mechanisms. Recently, global and Japanese guidelines for COPD have been published. These guidelines seem to be useful to improve the underdiagnosis and undertreatment of COPD. In this review, I describe briefly the current recommendation for pharmacological therapy of stable COPD according to the global and Japanese guidelines for COPD.

Administration, Inhalation↗